Marketed in Spain the first medication derived from cannabis to treat refractory epilepsy
From September 2021, Cannabidiol (CBD) will be marketed in Spain as the first medication used to treat refractory epilepsy, which does not respond we1
Unit News from Epilepsia
Lockdown resulted in an increase in epileptic seizures in 1 in 4 patients
Approximately a quarter, 25.8%, of patients had seizures more frequently than before lockdown. Half felt more anxious or depressed than us1